Target intelligence / Profile preview

Conjugated bile salts

Molecular classification
Steroid derivative, Lipid, Other
01

Overview

Conjugated bile salts are steroid-derived amphipathic molecules synthesized in the liver from cholesterol and conjugated with glycine or taurine to increase their solubility at physiological pH (PubChem: Bile Acids and Salts, 2024). Secreted into the intestinal lumen via the biliary tract, they play a critical role in the emulsification and absorption of dietary lipids and fat-soluble vitamins. Beyond digestion, they serve as important signaling molecules that activate the farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor (TGR5), thereby regulating lipid, glucose, and energy homeostasis (Journal of Lipid Research: Bile acids as signaling molecules, 2009). In clinical practice, these molecules are targeted by bile acid sequestrants, which are non-absorbable resins that bind bile salts in the gut to prevent their reabsorption in the terminal ileum. This interruption of the enterohepatic circulation prompts the liver to upregulate the conversion of endogenous cholesterol into new bile acids, effectively lowering serum low-density lipoprotein (LDL) cholesterol levels (NIH: LiverTox - Bile Acid Sequestrants, 2020). Consequently, they are key targets in the management of hypercholesterolemia and certain cholestatic liver diseases (StatPearls: Bile Acid Sequestrants, 2023).

Other names
Conjugated bile acidsBile saltsGlyco-conjugated bile acidsTauro-conjugated bile acidsBile acid conjugates
02

Mechanism of action

Bile acid sequestration and interruption of enterohepatic circulation

03

Biological functions

Lipid emulsificationCholesterol homeostasisSignal transductionMetabolic regulationOther
04

Disease associations

HypercholesterolemiaBile acid malabsorptionCholestatic pruritusType 2 diabetes mellitusCardiovascular diseaseOther
05

Safety considerations

Malabsorption of fat-soluble vitamins (A, D, E, and K)Gastrointestinal distress including constipation and bloatingInterference with the absorption of co-administered medications (e.g., warfarin, digoxin, thiazides)Potential for hypertriglyceridemia in susceptible patients
06

Interacting drugs

Cholestyramine

2 more in the full profile.

07

Biomarkers

Low-density lipoprotein cholesterol (LDL-C)7α-hydroxy-4-cholesten-3-one (C4)Fecal bile acid excretionFibroblast growth factor 19 (FGF19)

Beyond the preview

Go deeper on Conjugated bile salts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conjugated bile salts.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call